These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 5427901)

  • 21. [The tuberculin test in cancer patients].
    Yarom J; Robinson E
    Harefuah; 1972 Dec; 83(12):542-3. PubMed ID: 4659021
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adrenal steroids in patients with breast cancer and in women with age-related impaired glucose tolerance].
    Odin VI; Tsyrlina EV; Gamaiunova VB; Bershteĭn LM
    Vopr Onkol; 1996; 42(4):22-6. PubMed ID: 8928452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of a human embryonic antigen complex in studying the immune response in cancer patients].
    Gorodilova VV; Mandrik EV; Ul'chenko VM
    Vopr Onkol; 1982; 28(1):23-7. PubMed ID: 7199781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic responses in cancer patients.
    Solowey AC; Rapaport FT
    Surg Gynecol Obstet; 1965 Oct; 121(4):756-60. PubMed ID: 5838283
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
    Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients.
    Lundgren S; Helle SI; Lonning PE
    Clin Cancer Res; 1996 Sep; 2(9):1515-21. PubMed ID: 9816328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune status in patients cured of breast and gynaecological cancer.
    Haim N; Rudik L; Samuelly B; Mekori T; Robinson E
    Clin Oncol; 1981 Jun; 7(2):141-7. PubMed ID: 7249436
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic responses in cancer patients.
    Solowey AC; Rapaport FT
    Surg Forum; 1965; 16():100-1. PubMed ID: 5835105
    [No Abstract]   [Full Text] [Related]  

  • 31. [Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer].
    Blossey HC; Wander HE; Nagel GA; Köbberling J; Kleeberg U
    Onkologie; 1982 Aug; 5 Suppl():34-41. PubMed ID: 6290955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum sex hormones and breast cancer risk factors in postmenopausal women.
    Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.
    Ryan CJ; Halabi S; Ou SS; Vogelzang NJ; Kantoff P; Small EJ
    Clin Cancer Res; 2007 Apr; 13(7):2030-7. PubMed ID: 17404083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
    Cervantes C; Muzio E; Exposito G; Garcia ME
    Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens.
    Kamenicky P; Houdoin L; Ferlicot S; Salenave S; Brailly S; Droupy S; Meduri G; Sasano H; Suzuki T; Young J; Chanson P
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):778-88. PubMed ID: 17408424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer.
    Avigan D; Wu Z; Joyce R; Elias A; Richardson P; McDermott D; Levine J; Kennedy L; Giallombardo N; Hurley D; Gong J; Kufe D
    Bone Marrow Transplant; 2000 Jul; 26(2):169-76. PubMed ID: 10918427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Delayed hypersensitivity by concentrated tuberculin].
    Yoshida T; Hashimoto T
    Arerugi; 1966 Feb; 15(2):117-23. PubMed ID: 5960454
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tuberculin hypersensitivity in patients with respiratory tuberculosis].
    Musić N; Simeonov L
    Tuberkuloza; 1965; 17(4):339-48. PubMed ID: 5871210
    [No Abstract]   [Full Text] [Related]  

  • 39. The significance of tuberculin immunity testing in cancer patients.
    Mujagić H; Desković M; Malenica B; Bistrović M; Nola P; Krusić J
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(2):111-21. PubMed ID: 7471135
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cutaneous delayed hypersensitivity in breast cancer before therapy].
    Lang JM; Giron C; Bergerat JP; Haehnel P; Jaeck D; Bellocq JP; Oberling F
    Presse Med; 1983 Dec; 12(45):2885. PubMed ID: 6228869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.